Literature DB >> 16889597

Direct versus indirect allorecognition: Visualization of dendritic cell distribution and interactions during rejection and tolerization.

J C Ochando1, N R Krieger, J S Bromberg.   

Abstract

Interactions of donor and recipient dendritic cells (DCs) with CD4+ T cells determine the alloantigenic response in organ transplantation, where recipient T cells respond either directly to donor MHC, or indirectly to processed donor MHC allopeptides in the context of recipient MHC molecules. The present study evaluates donor and recipient alloantigen-presenting DC trafficking and their interactions with CD4+ T cells in the lymph nodes (LNs) and the spleen under tolerogenic treatment with anti-CD2 plus anti-CD3 mAb compared with untreated rejecting conditions. CX3CR1(GFP) BALB/c (I-A(d)) donor hearts were transplanted into C57BL/6 (I-A(b)) mice and quantification of donor DC direct (GFP+ or I-A(d+)) and recipient DC indirect (YAe+) trafficking and interactions with host CD4+ T cells was performed by fluorescent microscopy. Our data indicate that although both direct and indirect interactions between CD4+ T cells and donor and recipient DCs occur shortly after engraftment, only indirect presentation persists in the LN, but not the spleen, of tolerized recipients. These data suggest that distinct anatomic lymphoid compartments play a critical role in peripheral tolerance induction and maintenance, and persistent indirect presentation to CD4+ T cells within the LNs is an important process during tolerization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16889597     DOI: 10.1111/j.1600-6143.2006.01494.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  20 in total

1.  Lymphotoxin-beta receptor blockade induces inflammation and fibrosis in tolerized cardiac allografts.

Authors:  Y Nakayama; J S Bromberg
Journal:  Am J Transplant       Date:  2012-05-17       Impact factor: 8.086

Review 2.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

3.  Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy.

Authors:  Susanna Celli; Matthew L Albert; Philippe Bousso
Journal:  Nat Med       Date:  2011-05-15       Impact factor: 53.440

Review 4.  Autoantibody formation in human and rat studies of chronic rejection and primary graft dysfunction.

Authors:  David S Wilkes
Journal:  Semin Immunol       Date:  2011-09-16       Impact factor: 11.130

5.  Epidermal Langerhans cells promote skin allograft rejection in mice with NF-kappa B-impaired T cells.

Authors:  L L Molinero; P Zhou; Y Wang; H Harlin; B Kee; C Abraham; M L Alegre
Journal:  Am J Transplant       Date:  2007-11-16       Impact factor: 8.086

Review 6.  Role of secondary lymphoid tissues in primary and memory T-cell responses to a transplanted organ.

Authors:  Yue-Harn Ng; Geetha Chalasani
Journal:  Transplant Rev (Orlando)       Date:  2009-10-20       Impact factor: 3.943

7.  Divergent role of donor dendritic cells in rejection versus tolerance of allografts.

Authors:  Takuya Ueno; Katsunori Tanaka; Mollie Jurewicz; Takaya Murayama; Indira Guleria; Paolo Fiorina; Jesus C Paez; Andrea Augello; Andrea Vergani; Masie Wong; R Neal Smith; Reza Abdi
Journal:  J Am Soc Nephrol       Date:  2009-01-07       Impact factor: 10.121

Review 8.  Humoral immunity and the development of obliterative bronchiolitis after lung transplantation: is there a link?

Authors:  Amir M Emtiazjoo; David S Wilkes
Journal:  Am J Respir Cell Mol Biol       Date:  2012-10-18       Impact factor: 6.914

Review 9.  Dendritic cells and chemokine-directed migration in transplantation: where are we headed?

Authors:  Bridget L Colvin; Benjamin M Matta; Angus W Thomson
Journal:  Clin Lab Med       Date:  2008-09       Impact factor: 1.935

10.  Inhibition of arterial allograft intimal hyperplasia using recipient dendritic cells pretreated with B7 antisense peptide.

Authors:  Yu-Feng Yao; Yi-Ming Zhou; Jian-Bin Xiang; Xiao-Dong Gu; Duan Cai
Journal:  Clin Dev Immunol       Date:  2012-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.